6 results for author:"Barassi F." in Literature citations
Results Customize
› Repeat search in UniProtKB (4)
| Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung. Marchetti A., Felicioni L., Pelosi G., Del Grammastro M., Fumagalli C., Sciarrotta M., Malatesta S., Chella A., Barassi F., Mucilli F. et al. |
| Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas. Barbareschi M., Buttitta F., Felicioni L., Cotrupi S., Barassi F., Del Grammastro M., Ferro A., Dalla Palma P., Galligioni E., Marchetti A. Clin. Cancer Res. 13:6064-6069(2007) · Mapped (7) |
| PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma. Buttitta F., Felicioni L., Barassi F., Martella C., Paolizzi D., Fresu G., Salvatore S., Cuccurullo F., Mezzetti A., Campani D. et al. |
| Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization. Giglio S., Mancini F., Gentiletti F., Sparaco G., Felicioni L., Barassi F., Martella C., Prodosmo A., Iacovelli S., Buttitta F. et al. Cancer Res. 65:9687-9694(2005) · UniProtKB (1) |
| Int6 expression can predict survival in early-stage non-small cell lung cancer patients. Buttitta F., Martella C., Barassi F., Felicioni L., Salvatore S., Rosini S., D'Antuono T., Chella A., Mucilli F., Sacco R. et al. Clin. Cancer Res. 11:3198-3204(2005) · Mapped (4) |
| Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcome. Marchetti A., Barassi F., Martella C., Chella A., Salvatore S., Castrataro A., Mucilli F., Sacco R., Buttitta F. Clin. Cancer Res. 10:1338-1343(2004) · Mapped (1) |